Methods: Children with SCD and age and gender matched controls were prospectively enrolled in a multi-center study. SCD subjects were reassessed two years later. Each subject underwent echocardiography (echo), hematologic testing, and 6-minute walk (6MW). Echo variables were compared from both visits with paired t-test and used to predict a decline in the 6MW by linear regression analysis with robust standard error estimate.
Results: 6MW data were available in 155 of 220 SCD subjects undergoing baseline and follow-up evaluation. Median age at initial visit was 13 years (range 9 -16 years) and median follow up time was 21.5 months. There were no significant changes in TRV, left ventricular diastolic dimension z-score (LVDDz), mitral valve E/E', blood pressure, and hemoglobin from baseline. No variable alone predicted a decline in 6MW. However, subjects who had a combination of an elevated TRV (>2.6 m/sec as defined by 95% in control population) and LVDDz (>2) at the initial visit had a significant decrease in their 6MW ( Yes -56 (0.049) -60 (0.020) -63 (0.017) 5 p value (compared to row 1) in parenthesis Conclusions: The combination of elevated TRV and LVDDz predicts declining 6MW performance in children with SCD. This subset of patients with both mild pulmonary hypertension and volume overload may be at increased risk for morbidity.
